Mizuho raised the firm’s price target on HCA Healthcare (HCA) to $540 from $520 and keeps an Outperform rating on the shares. The firm cites the company’s “solid” Q4 performance for the target boost.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $481 from $452 at Wells Fargo
- HCA Healthcare price target raised to $555 from $525 at RBC Capital
- HCA Healthcare price target raised to $529 from $490 at TD Cowen
- HCA Healthcare price target raised to $598 from $525 at UBS
- HCA Healthcare price target raised to $540 from $500 at Oppenheimer